Vivimed Labs Limited (VIVIMEDLAB) — Financial Results

· NSE 🔴 High Importance Neutral

Vivimed Labs Limited announced a postponement of its scheduled board meeting on May 30, 2026, which was intended to approve financial results for the quarter and year ended FY 2025-2026. The meeting has been delayed, and the new date will be communicated later. The trading window for designated persons remains closed until 48 hours after the rescheduled results announcement. The company did not disclose financial figures or growth metrics in this announcement.

📄 View Original Announcement (PDF)

About Vivimed Labs Limited (VIVIMEDLAB)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹61.27 Cr P/E: -4.4

View full VIVIMEDLAB stock details →

📡 Get AI alerts when VIVIMEDLAB files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track VIVIMEDLAB — Free

📊 More VIVIMEDLAB filings

See all VIVIMEDLAB filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when VIVIMEDLAB files new disclosures

Track VIVIMEDLAB filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track VIVIMEDLAB — Free

Free account · 2 AI queries/day